Antiplatelet Therapy in Neuroendovascular Therapeutics

Authors

David Fiorella
Lucie Thiabolt
Felipe C. Albuquerque, Barrow Neurological InstituteFollow
Vivek R. DeshmukhFollow
Cameron G. McDougall
Peter A. Rasmussen

Department

neurosurgery

Document Type

Article

Abstract

Our understanding of the pharmacology of antiplatelet therapy continues to evolve rapidly. Although the existing data are primarily generated in the setting of interventional and preventative cardiology studies, these data may be extrapolated to guide the rational application of these agents in neuroendovascular procedures. Platelet function testing represents an increasingly available and practical method by which to verify the adequacy of therapy and guide clinical decision making. The optimal application of these agents will undoubtedly improve the risk profile of neuroendovascular procedures, increase the success rate of acute stroke intervention, and facilitate more effective secondary stroke prevention. © 2005 Elsevier Inc. All rights reserved.

Publication Date

2005

Publication Title

Neurosurgery Clinics of North America

ISSN

1042-3680

Volume

16

Issue

3

First Page

517

Last Page

540

Digital Object Identifier (DOI)

10.1016/j.nec.2005.03.003

Recommended Citation

Fiorella, David; Thiabolt, Lucie; Albuquerque, Felipe C.; Deshmukh, Vivek R.; McDougall, Cameron G.; and Rasmussen, Peter A., "Antiplatelet Therapy in Neuroendovascular Therapeutics" (2005). Neurosurgery. 37.
https://scholar.barrowneuro.org/neurosurgery/37